Clinical studies demonstrated that the serum TSP2 level correlated significantly with hepatocyte ballooning, lobular inflammation, and fibrosis stage in patients with NAFLD [50,51]. This evidence concerns the gene THBS2 and metabolic dysfunction-associated steatotic liver disease.